Canada Spends Logo

Explore our Budget 2026 analysis

Grant: New Investigator Award: PA - Infection and Immunity

Ottawa Hospital Research Institute

$300,000.00

A discovery pipeline for small molecule enhancers of viral therapeutics

FY 2015-16

Summary
Viral sensitizers are small molecules discovered in the Diallo laboratory that boost viral infection. These have a wide range of potential uses, including cancer treatment, gene therapy, and vaccine manufacturing. We propose to further our understanding of the mechanism of action of our growing collection of viral sensitizers and further explore their therapeutic and industrial applications. We believe this research will lead to improvements in health care on multiple fronts, including better treatments for cancer and genetic illnesses, as well as increased availability and reduced cost of vaccines for viral diseases such as such as influenza.
Program
New Investigator Award: PA - Infection and Immunity
Location
Ontario, Canada
Recipient Type
Other
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
341428
Name
Diallo Jean-Simon
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
New Investigators C
Projecttitle
A discovery pipeline for small molecule enhancers of viral therapeutics
Programtype2
Salary Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$300,000
Cihrequipment2
$0
Programname2
New Investigator Award: PA - Infection and Immunity
Keyworddelim
Cancer; Genetherapy; Innate Immunity; Oncolytic Virus; Small Molecule; Vaccine Manufacturing; Viral Sensitizer; Virus
Abstract
Viral sensitizers are small molecules discovered in the Diallo laboratory that boost viral infection. These have a wide range of potential uses, including cancer treatment, gene therapy, and vaccine manufacturing. We propose to further our understanding of the mechanism of action of our growing collection of viral sensitizers and further explore their therapeutic and industrial applications. We believe this research will lead to improvements in health care on multiple fronts, including better treatments for cancer and genetic illnesses, as well as increased availability and reduced cost of vaccines for viral diseases such as such as influenza.
Competitiondate
201512
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Diallo, Jean-Simon
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $300,000~ $0~